Mark A. Chaney, MD
Precose dosages: 50 mg, 25 mg
Precose packs: 60 pills, 90 pills, 120 pills, 180 pills, 270 pills, 360 pills
Comparative outcomes and assessment of trifecta in 500 robotic and laparoscopic partial nephrectomy cases: a single surgeon experience diabetes insipidus after pituitary surgery cheap 25 mg precose with visa. A matched comparison of perioperative outcomes of a single laparoscopic surgeon versus a multisurgeon robot-assisted cohort for partial nephrectomy. Robotic-assisted versus traditional laparoscopic partial nephrectomy: comparison of outcomes and evaluation of learning curve. Cryoablation versus radiofrequency ablation for renal tumor ablation: time to reassess Histopathologic confirmation of complete cancer-cell kill in excised specimens after renal cryotherapy. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation. Systematic review and meta-analysis of perioperative and oncologic outcomes of laparoscopic cryoablation versus laparoscopic partial nephrectomy for the treatment of small renal tumors. Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup. Comparison of percutaneous radiofrequency ablation and open partial nephrectomy for the treatment of size- and location-matched renal masses. Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors. Oncological outcomes utilizing real-time peripheral thermometry-guided radiofrequency ablation of small renal masses. Long-term oncologic outcomes after radiofrequency ablation for t1 renal cell carcinoma. Systematic review and meta-analysis of thermal ablation versus surgical nephrectomy for small renal tumours. Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance. A prospective, comparative study of quality of life among patients with small renal masses choosing active surveillance and primary intervention. Excise, ablate or observe: the small renal mass dilemma-a metaanalysis and review. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis. Most renal oncocytomas appear to grow: observations of tumor kinetics with active surveillance.
Distinct P-cadherin expression in cultured normal human keratinocytes and squamous cell carcinoma cell lines managing diabetes quiz safe 50 mg precose. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study. Squamous cell carcinoma of the skin-histopathological features and their significance for the clinical outcome. Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis. Metastatic cutaneous squamous cell carcinoma: the importance of T2 stratification and hematologic malignancy in prognostication. Intransit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients. Evaluation of the American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma and proposal of a new staging system. A statistical study of 1,341 skin tumors comparing results obtained with irradiation, surgery, and curettage followed by electrodesiccation. Salvage cisplatin and Adriamycin for advanced or recurrent basal or squamous cell carcinoma of the face. Follow-up on programmed cell death 1 inhibitor for cutaneous squamous cell carcinoma. High-risk cutaneous squamous cell carcinoma and the emerging role of sentinel lymph node biopsy: a literature review. Comparison of oncostatin M expression in keratoacanthoma and squamous cell carcinoma. Trisomy 7 in keratoacanthoma and squamous cell carcinoma detected by fluorescence in-situ hybridization. Keratoacanthomas frequently show chromosomal aberrations as assessed by comparative genomic hybridization. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin. Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma. Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma.
Management of Regional Lymph Nodes the surgical management of clinically normal lymph nodes is determined by the characteristics of the primary melanoma diabetic drinks precose 50 mg purchase online. There is a direct relationship between thickness of the melanoma and risk of regional lymph node involvement. With truncal or head and neck primary lesions, drainage to more than one nodal basin can occur, and it is important to retrieve the sentinel node(s) from each node basin in which a sentinel node is identified during lymphoscintigraphy. A vital blue dye (1% isosulfan blue) injected into the skin directly next to the melanoma is also used intraoperatively to further assist with the localization of the sentinel nodes. Analysis of the sentinel nodes is performed after the tissue has been fixed in formalin, because frozen section analysis has a decreased accuracy. Multiple sections are taken of the node and evaluated with immunohistochemical stains. Most patients who were randomized to the nodal observation group and who developed a regional recurrence received a radical lymphadenectomy because the regional nodes remained the solitary site of metastatic disease. The 3-year rate of melanoma-specific survival was similar in the two groups (86% for both groups; P =. The study was limited, however, by relatively short follow-up and poor accrual with smaller than planned sample size. These patients may now be offered serial ultrasound examination of the regional lymph basin with additional surgery only if regional disease recurrence is detected. Systemic Adjuvant Therapy Postoperative adjuvant therapy or adjuvant therapy clinical trials should be considered for patients with a high risk for recurrence. Previously, adjuvant ipilimumab at a dose of 10 milligrams per kilogram had also demonstrated an overall survival benefit compared to placebo; however its use in the adjuvant setting was limited due to the high risk of toxicity with this dose. Adjuvant high-dose interferon is also approved based on older trials demonstrating a recurrencefree survival advantage; however, there is no clear overall survival benefit. In a randomized trial of 870 patients, dabrafenib and trametinib resulted in a rate of 3-year relapse-free survival of 58% compared to 39% in the placebo group. The 3-year overall survival rate was 86% with the combination therapy compared to 77% with placebo. Patients with confirmed nodal metastases should undergo a staging evaluation for distant metastatic disease before undergoing a lymph node dissection. Therapeutic axillary dissection carries an approximately 10% to 15% risk of lymphedema in the upper extremity. Therapeutic inguinal dissections most commonly consist of a superficial groin dissection. Inguinal dissection wounds can have an appreciable infection rate of at least 10% to 15%. Early recognition and aggressive measures to treat lymphedema can reduce the morbidity of this complication. The risk of regional recurrence sometimes can be lowered by judicious use of radiation therapy after lymphadenectomy in selected patients at particularly high risk, such as those with four or more positive nodes or bulky nodal disease with extracapsular extension. Although there are no prospective randomized studies showing a superior survival outcome with the addition of postoperative radiation, retrospective studies have suggested that radiation may improve regional control in patients at particularly high risk for local recurrence.
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis diabetes symptoms babies best precose 25 mg. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. Quality of life after palliative treatment for oesophageal carcinoma-a prospective comparison between stent placement and single dose brachytherapy. Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer. Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinoma. Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. Successful treatment of esophageal cancer with airway invasion with induction chemotherapy and concurrent chemoradiotherapy. Efficacy analysis of simplified intensity-modulated radiotherapy with high or conventional dose and concurrent chemotherapy for patients with neck and upper thoracic esophageal carcinoma. Thirty-four patients with carcinoma of the cervical esophagus treated with chemoradiation therapy. Swallowing function in patients with esophageal cancer treated with concurrent radiation and chemotherapy. Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia.
Whether Japanese patients were able to receive more second-line and beyond therapy because of more favorable tumor biologic features that led to a slower decline in performance status diabetes zoo walk precose 25 mg discount, superior oncologic care, or some other factor is not known. The only toxicity more common in the ramucirumab arm was grade 3 hypertension in 8% of patients. When ramucirumab was combined with paclitaxel, the only other toxicity observed in addition to hypertension was a higher incidence of grade 3/4 neutropenia (41% versus 19%) but not a higher rate of neutropenic fever (3. The activity and tolerability of this regimen led to its approval in November 2014 and has established it as the standard of care in the second-line setting. Individually, each of these studies has been negative; collectively, they have dampened enthusiasm for further evaluation of these drugs in an unselected population. Again, toxicities were increased in the cetuximab arm, including grade 3/4 diarrhea, rash, hand-foot syndrome, and hypomagnesemia. The study closed because of slow accrual, and results have yet to be presented (ClinicalTrials. However, it was stopped after a preplanned analysis of the first 180 patients who had completed 24 weeks of follow-up occurred because it met predetermined criteria for futility. The primary end point of being free of treatment failure at 24 weeks was lower in the cetuximab arm (66. Patients who received cetuximab were less likely to receive or complete standard chemoradiation and also had higher rates of dermatologic and metabolic toxicities. There was no difference in outcomes between both arms, confirming a lack of benefit for cetuximab combined with chemoradiation. Immunotherapy There has been growing excitement among oncologists and patients alike regarding the use of immunotherapy or, more specifically, immune checkpoint inhibitors. In addition to this primary signal, a secondary signal is required, in the absence of which the T cell may be rendered anergic or nonfunctional. It is now well established that the interactions between multiple molecules at the interface between the T cell and tumor cell create multiple secondary signals, some of which are costimulatory and some of which are inhibitory. Under normal physiologic conditions, immune checkpoints are crucial for the maintenance of self-tolerance (and the avoidance of autoimmunity) and also for protection of tissues from excessive damage if the immune system were to respond too exuberantly to an infection. However, many of these molecules have become co-opted by cancer cells (in the process of achieving equilibrium and escape from the immune system). Their identification and targeting with neutralizing (or agonist) antibodies now form the basis of modern era immunotherapy. This delivers an inhibitory signal to those T cells, preventing them from killing target cancer cells and protecting the tumor from immune elimination.
Syndromes
Although complete resection of the malignancy is of paramount importance managing diabetes bob greene best precose 50 mg, reconstruction of the surgical defect must be designed so that the patient has an opportunity to regain as much speech and swallowing function as possible. The ability of the patient to participate in postoperative rehabilitation should also be reviewed. Patients who are emotionally or socially unable to participate should be identified early in the decision-making process. In general, primary surgical therapy is selected for patients with tumors of the oral cavity, skin, salivary gland, paranasal sinus, thyroid, selected early-stage or advanced-stage larynx cancer, and carefully selected lesions of the oropharynx. Patients with very advanced tumors invading bone, destroying cartilage, or extending into the soft tissues of the neck are considered for primary surgical therapy. When patients have severe organ dysfunction as a consequence of cancer infiltration, surgery should be considered because functional restoration with nonsurgical therapy is unlikely. This procedure is indicated in the setting of high-volume neck metastases involving these nonlymphatic structures. A modified radical neck dissection removes lymph nodes from all five levels of the neck but spares one or more of the nonlymphatic structures. Selective neck dissections involve the resection of fewer than all five levels of lymph nodes, usually involving three or four levels according to the site of the primary cancer. With fractionation, issues of patient immobilization and treatment setup reproducibility become important considerations. For the head and neck, critical normal tissue structures such as the spinal cord, brainstem, and optic chiasm often are in close proximity to the irradiated target. Immobilization addresses the issue of the precision of the treatment delivery as a strategy to optimize the therapeutic ratio. In these cases, the oncologist would outline the areas to irradiate on a radiograph of the head and neck. Currently, the basis for this determination is derived from surgical and clinical documentation of disease extension that is often unique to each head and neck subsite. The identification of nodal groups typically at risk for harboring subclinical nodal metastases has proven more difficult. To aid in this identification, several reports have defined axial anatomic structures that may be used to delineate the various nodal groups (Table 65. Of note, however, when prior treatment to the neck has occurred, altered flow of lymphatics is a concern. As with head and neck surgery, judgment must be exercised with these precise treatment techniques. The former has proven to be more amenable to therapeutic manipulation with the use of altered fractionation schedules, which may be generalized into two groups: hyperfractionation and accelerated fractionation.
Necrosis was divided into three categories: good (100% to 80% necrosis) diabetic diet guidelines mayo clinic 25 mg precose purchase fast delivery, fair (80% to 50% necrosis), and poor (<50% necrosis). Depending on the system that is used, tumor necrosis ranging from 60% to 95% is common. Winkler and associates120 were early to report that patients with unfavorable pathologic responses to preoperative chemotherapy experienced a poorer (49%) disease-free survival than did patients with a favorable pathologic response (87%; P =. Continuous disease-free survival for the overall group was 70% at 5 years and 69% at 10 years. The only independent predictor of a favorable outcome was found to be the histopathologic response to chemotherapy as defined by pathologic review of the surgical specimen. A literature review by Davis and colleagues169 attempted to identify prognostic factors that could influence survival in patients with nonmetastatic high-grade osteosarcoma of the extremities. Eight previously reported large series of patients included sufficient data to evaluate the numerous identified variables. Only two variables proved significant to univariate analysis: tumor size and chemotherapy-induced tumor necrosis after primary chemotherapy. Other large series have demonstrated similar prognostic responses to neoadjuvant chemotherapy. The table suggests that results have improved owing to management by multiagent neoadjuvant chemotherapy combined with adequate local surgery performed by experienced musculoskeletal surgeons. Although, in general, local recurrence is higher in patients with inadequate margins, some patients who are so treated do not have recurrence, whereas in some patients with wide or radical margins, disease does recur or persist locally. The effect of neoadjuvant chemotherapy in this regard is suspected to be beneficial, but only retrospective data are available. Of the 271 margins reported by Memorial Sloan-Kettering, 266 were adequate (261 wide and 5 radical), and five were inadequate (three marginal and two intralesional). Of the 18 locally persistent tumors, however, all developed in patients who were thought to have wide margins. There were no locally recurrent tumors from the five known inadequate surgical margins. Only two local recurrences developed, one in a patient having an intralesional amputation and the other with a marginal resection and reconstruction. A similar review from Birmingham, England, revealed 23 marginal and 15 intralesional margins in 99 patients, with a 4. There were 28 patients who experienced local recurrence (7%), three of whom survived (11%). Six of 10 patients who did not receive preoperative chemotherapy had local recurrence. In the other limb salvage procedures, 110 patients had wide margins, 12 were marginal, seven had intralesional margins, and seven had wide contaminated margins. Although 27 patients had inadequate margins, only three developed local recurrence, all within the first 2 years after diagnosis. The most common anatomic site for inadequate margins was the popliteal region near the vascular and neural structures, where 20 of 140 patients were found to have inadequate margins (either marginal or intralesional).
Target genes of beta-catenin-T cell-factor/lymphoid-enhancer factor signalling in human colorectal carcinomas diabetes definition mg/dl buy precose 50 mg on-line. Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Compound disruption of Smad2 accelerates malignant progression of intestinal tumors in Apc knockout mice. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Allelic profiles of mononucleotide repeat microsatellites in control individuals and in colorectal tumors with and without replication errors. Deficient mismatch repair system in patients with sporadic advanced colorectal cancer. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. The cost-effectiveness of routine testing for Lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Colorectal cancer intrinsic subtypes, predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition. Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer. Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Gene expression classification of colon cancer into molecular subtypes: characterization, validation and prognostic value. Challenging the cancer molecular stratification dogma: intratumoral heterogeneity undermines consensus molecular subtypes and potential diagnostic value in colorectal cancer. Cancercell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification. Changing the paradigm- multistage multiarm randomized trials and stratified cancer medicine. Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection.
No significant difference was found in the 4-year disease-free survival rates between the two arms diabetes pancreas discount precose 25 mg without prescription, but the rate of paraaortic node recurrence was significantly higher in patients in whom that area was not treated. Some investigators have suggested resections of nodes larger than 2 cm before radiation therapy. Several investigators have reported high local control rates in patients treated with excision of bulky nodes and radiation; however, the numbers of patients in these series are small. Recurrent Disease Recurrent disease carries a poor prognosis, but there are two clinical factors that are commonly correlated with a higher probability of success of salvage therapy. The two factors are location (central versus sidewall involvement) and the size of the recurrent pelvic tumor. In most patients, treatment consists of external beam radiation therapy with or without brachytherapy. Patients who have isolated central recurrences without pelvic wall fixation or regional metastasis can be cured in up to 60% to 70% of cases. There are insufficient data on the addition of chemotherapy to radiation therapy; however, if there is no contraindication, concurrent chemotherapy should be considered. Pelvic exenteration is a potentially curative procedure for patients who, after radiation therapy, have a central pelvic recurrence or a new primary tumor in the irradiated field. Brachytherapy often is compromised or impossible to perform because vesicovaginal fistulas develop before diagnosis or during treatment. Regional Disease Most patients treated with radical hysterectomy who are found to have lymph node metastases require postoperative radiation therapy. On the basis of the findings of Peters and colleagues,108 concurrent chemotherapy is recommended if no medical contraindications are present. Patients with paraaortic node involvement can be treated effectively with extended-field irradiation. Coleman and colleagues reported on 50 patients treated with radical hysterectomy for recurrent central disease after definitive radiation. Unfortunately, in most series, responses to cisplatin are short-lived (3 to 6 months). The median duration of response for complete responders is 6 months, and the median survival is only 9 months. A limited number of reasonably well-powered randomized trials comparing these doublets with either triplet regimens or singlet regimens have demonstrated that combination therapy leads to a slightly higher response rate and a longer progression-free survival but does not appear to affect overall survival,219,220 and response rates decrease significantly if patients have had previous radiation.
Primary Therapy diabetes medications brand names 25 mg precose order fast delivery, Locally Advanced Disease, and Treatment of Metastatic Disease As with colorectal adenocarcinoma, the primary therapy for localized small bowel adenocarcinoma is radical segmental resection including associated mesentery and lymph nodes. Adequate nodal resection provides vital information for staging and for clearance of early lymph node metastases. For tumors of the duodenum, pancreaticoduodenectomy has traditionally been performed; however, a retrospective analysis of 1611 patients from 1988 to 2010 who underwent resection of a primary duodenal tumor did not find a survival benefit to pancreaticoduodenectomy compared with segmental resection, indicating that segmental resection is an appropriate strategy if negative margins can be obtained. Despite the high observed/expected ratio reported for small bowel cancers in regional enteritis (30 to >100), it is impossible to prove a statistical increase because of the overall low incidence of small bowel cancers. Preoperative diagnosis was made in only 2 of 19 patients in the earlier described series. In a retrospective multicenter study, a combination of fluoropyrimidine and oxaliplatin produced the longest progression-free and overall survival. As discussed previously, carcinoid tumors of the small intestine appear to be increasing in incidence and can occur in patients ranging from 20 to 80 years old, with predominance in the 60s. Potential causes include small bowel obstruction or kinking, and vascular compromise from bulky mesenteric nodal masses or the vasoconstricting local effects of serotonin secretion. Carcinoid tumors are most often located in the ileum, within 60 cm of the ileocecal valve. In 30% of cases, multiple nodules exist, making adequate evaluation of the entire length of bowel mandatory. The most common symptoms include watery diarrhea and episodic flushing of the body, usually triggered by exercise or consumption of chocolate, blue cheese, alcohol, or red wine. Carcinoid crisis is a life-threatening form of the carcinoid syndrome, often precipitated by surgery, anesthesia, or chemotherapy. It manifests as intense bronchospasm, flushing, diarrhea, and hemodynamic instability with tachycardia and hypotension, and altered mental status. Five-year survival rate in colorectal cancer is about 46%, versus 23% in small bowel cancer. Primary therapy, locally advanced disease, and treatment of metastatic disease Treatment of nonmetastatic disease consists of segmental resection of the affected portion of bowel in addition to the associated mesentery. Thorough examination of the remainder of the bowel should be performed to rule out and resect any synchronous lesions. In metastatic cases, surgery may be indicated for palliation of bleeding, obstruction, ischemia, or other local symptoms related to either the primary lesion or mesenteric metastases. Excision or ablation of liver metastases can be performed to lessen the symptoms of carcinoid syndrome. Systemic treatment with long-acting somatostatin analogues such as octreotide are used in patients with metastatic carcinoid to alleviate symptoms. A randomized study on the use of octreotide in these patients showed a decreased rate of tumor growth, but no significant change in overall survival.
Marius, 52 years: Hepatic arterial infusion chemotherapy with continuous low dose administration of cisplatin and 5-fluorouracil for multiple recurrence of hepatocellular carcinoma after surgical treatment. Preoperative identification of sentinel nodes may further enhance the safety of this approach.
Spike, 57 years: The authors recommended platinum-based chemotherapy as the preferred regimen with consideration of multiple lines of chemotherapy and consideration of chemoradiotherapy for locoregional control and surgery with curative intent in appropriate patients. Neobladders rely on the rhabdosphincter for continence, and if the sphincter is functional, most patients achieve daytime continence with minimal (or manageable) nighttime incontinence.
Givess, 37 years: Primary prevention programs seek to target those exposures most closely linked to bladder cancer etiology. The one exception is that functioning nodules in children do carry a higher risk of malignancy.
Kalan, 39 years: In addition, dividing the thyroid isthmus can also facilitate medial rotation, assuming that the tumor is not located within the isthmus. Adenocarcinoma In North America and Japan, adenocarcinoma is the most common histologic type of lung cancer.
Aldo, 28 years: These researchers compared three-drug chemotherapy with cisplatin, doxorubicin, and high-dose methotrexate (regimen A) with the same three drugs with the addition of ifosfamide (regimen B). Radiographically, the lesion arises from the surface of the bone, contiguous with the cortex, producing a scalloped appearance.
Yespas, 59 years: Treatment of mucosal melanoma is often delayed significantly because of lack of early symptoms. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head.
Faesul, 43 years: Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. This histologic type is associated with a rapid clinical rate of growth, proclivity for early regional dissemination, and increased risk of recurrence after surgical therapy or radiation therapy, even in the absence of other recognized adverse prognostic factors.
Makas, 29 years: Added value of positron emission tomography imaging in the surgical treatment of colorectal liver metastases. There is a direct relationship between thickness of the melanoma and risk of regional lymph node involvement.
References